• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON CLAREON VIVITY TORIC EXTENDED VISION HYDROPHOBIC IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON CLAREON VIVITY TORIC EXTENDED VISION HYDROPHOBIC IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number CNWET3
Medical Device Problem Codes Use of Incorrect Control/Treatment Settings (1126); Optical Decentration (1360); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); Visual Impairment (2138)
Date of Event 04/11/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non-healthcare professional reported that following an intraocular lens (iol) implant procedure, the patient experienced blurry vision and clinical reason for explant was mechanical complication of iol.The iol was exchanged for unspecified advanced technology intraocular lenses (atiol) lens model 4 months 3 days following the initial implant procedure.Additional information has been requested.
 
Additional Manufacturer Narrative
Additional information was provided in h.3., h.6.And h.11.The product was not returned.All product and batch history records are quality reviewed prior to product release.Associated products were not provided.The product investigation could not identify a root cause for the reported complaint.The product was not returned.Each lens is subjected to a 100 percentage assessment of the power (spherical and cylinder) and optical resolution during the manufacturing process in order to determine acceptability per the lens model and diopter.Due diligence has been performed in an attempt to obtain further information on this event.The facility has not responded to requests for follow-up information.File will be reopened if new information or the sample is received.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information has been requested and received stating 4 weeks post op with no improvement in visual acuity.As per surgeon opinion poor centering iol caused event.The iol was exchanged for different diopter and different toric model company lens.The patient's issues were resolved and surgeon's prognosis was good.
 
Additional Manufacturer Narrative
The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
Additional information was provided in h.11.The product was not returned.Product history records were reviewed and documentation indicated the product met release criteria.Qualified associated products were provided.The product investigation could not identify a root cause for the reported complaint.The product was not returned.The product was not returned.Each lens is subjected to a 100 percentage assessment of the power (spherical and cylinder) and optical resolution during the manufacturing process in order to determine acceptability per the lens model and diopter.Information was provided that the toric company (1.50cyl), 19.5 diopter lens was replaced with a non-toric company, 18.5 diopter lens.The changed from a toric to a non-toric lens with a 1.0 change in diopter may indicated the replacement lens was an improved choice for the patient visual needs.The surgeon indicated the issue has subsided with the exchange.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON VIVITY TORIC EXTENDED VISION HYDROPHOBIC IOL
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key19423850
Report Number1119421-2024-01034
Device Sequence Number20835763
Product Code MJP
UDI-Device Identifier00380652466424
UDI-Public(01)00380652466424(17)260914(11)220916(10)15491876
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2024
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 02/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/14/2026
Device Model NumberCNWET3
Device Catalogue NumberCNWET3.195
Device Lot Number15491876
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/02/2024
Supplement Date Received by Manufacturer07/11/2024
12/05/2024
01/17/2025
Initial Report FDA Received Date05/30/2024
Supplement Report FDA Received Date08/06/2024
12/31/2024
02/12/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/16/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CLAREON MONARCH IV IOL DELIVERY SYSTEM, INJECTOR; DUOVISC VISCOELASTIC SYSTEM; MONARCH II IOL DELIVERY SYSTEM, CARTRIDGE B
Outcome Attributed to Adverse Event Required Intervention;
Patient Age57 YR
Patient SexFemale
-
-